{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:19:32Z","timestamp":1791004772521,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cmi.2015.12.005","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T01:48:53Z","timestamp":1472608133000},"page":"S120-S124","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S5","title":["Universal influenza vaccines: a realistic option?"],"prefix":"10.1016","volume":"22","author":[{"given":"R.D.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.F.","family":"Altenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2015.12.005_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cmi.2015.12.005_bib2","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.1244730","article-title":"Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution","volume":"342","author":"Koel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cmi.2015.12.005_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.4.21022","article-title":"Interim estimates of 2014\/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015","volume":"20","author":"Skowronski","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2015.12.005_bib4","first-page":"21025","article-title":"Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014\/15 mid-season results","volume":"20","author":"Pebody","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2015.12.005_bib5","doi-asserted-by":"crossref","first-page":"e0132195","DOI":"10.1371\/journal.pone.0132195","article-title":"Mid-season estimates of influenza vaccine effectiveness against influenza A(H3N2) hospitalization in the elderly in Quebec, Canada, January 2015","volume":"10","author":"Gilca","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.005_bib6","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cmi.2015.12.005_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virusres.2013.07.017","article-title":"Transmission of influenza A\/H5N1 viruses in mammals","volume":"178","author":"Imai","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.cmi.2015.12.005_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cell.2014.02.040","article-title":"Identification, characterization, and natural selection of mutations driving airborne transmission of A\/H5N1 virus","volume":"157","author":"Linster","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2015.12.005_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1222526","article-title":"The potential for respiratory droplet-transmissible A\/H5N1 influenza virus to evolve in a mammalian host","volume":"336","author":"Russell","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cmi.2015.12.005_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMc1502983","article-title":"Human infection with a novel avian influenza A(H5N6) virus","volume":"373","author":"Yang","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/cit479","article-title":"Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan","volume":"57","author":"Yuan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.005_bib12","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3201\/eid1012.040961","article-title":"Human illness from avian influenza H7N3, British Columbia","volume":"10","author":"Tweed","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.005_bib13","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","article-title":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2015.12.005_bib14","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib15","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JCM.43.11.5760-5767.2005","article-title":"Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003","volume":"43","author":"Butt","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2015.12.005_bib16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(14)60111-2","article-title":"Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study","volume":"383","author":"Chen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2015.12.005_bib17","doi-asserted-by":"crossref","first-page":"c7297","DOI":"10.1136\/bmj.c7297","article-title":"Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009","volume":"342","author":"Skowronski","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2015.12.005_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1164\/rccm.200912-1878CP","article-title":"Influenza A\/H1N1_09: Australia and New Zealand's winter of discontent","volume":"181","author":"Kotsimbos","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2015.12.005_bib20","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1128\/JVI.01203-13","article-title":"Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses","volume":"87","author":"Wan","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib21","doi-asserted-by":"crossref","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.cmi.2015.12.005_bib22","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/JVI.00585-15","article-title":"Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza A viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib24","doi-asserted-by":"crossref","first-page":"e26335","DOI":"10.1371\/journal.pone.0026335","article-title":"A\u00a0contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus","volume":"6","author":"Marcelin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.005_bib25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2015.12.005_bib26","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2015.12.005_bib27","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A\u00a0novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2015.12.005_bib28","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"LaMere","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2015.12.005_bib29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/CVI.00339-13","article-title":"In\u00a0vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein","volume":"20","author":"Bodewes","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2015.12.005_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/JVI.2.8.778-786.1968","article-title":"Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice","volume":"2","author":"Schulman","year":"1968","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/JVI.63.3.1239-1246.1989","article-title":"Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection","volume":"63","author":"Johansson","year":"1989","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vaccine.2012.10.065","article-title":"Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines","volume":"31","author":"Couch","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.005_bib33","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib34","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A\u00a0common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib35","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cmi.2015.12.005_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in\u00a0vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.cmi.2015.12.005_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.1308701110","article-title":"Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2015.12.005_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/JVI.02608-13","article-title":"Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain","volume":"88","author":"Eggink","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib40","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.vaccine.2014.11.054","article-title":"Virus-specific T cells as correlate of (cross-)protective immunity against influenza","volume":"33","author":"Altenburg","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.005_bib42","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1099\/vir.0.033076-0","article-title":"Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells","volume":"92","author":"Hillaire","year":"2011","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.005_bib44","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2009.05.079","article-title":"Infection of mice with a human influenza A\/H3N2 virus induces protective immunity against lethal infection with influenza A\/H5N1 virus","volume":"27","author":"Kreijtz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.005_bib45","doi-asserted-by":"crossref","first-page":"e1002381","DOI":"10.1371\/journal.ppat.1002381","article-title":"Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates","volume":"7","author":"Weinfurter","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2015.12.005_bib46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1084\/jem.165.2.408","article-title":"Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes","volume":"165","author":"Gotch","year":"1987","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib47","first-page":"3478","article-title":"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","volume":"118","author":"Lee","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cmi.2015.12.005_bib48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/267354a0","article-title":"Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses","volume":"267","author":"Zweerink","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2015.12.005_bib49","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02843-13","article-title":"Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus","volume":"88","author":"van de Sandt","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1099\/vir.0.048652-0","article-title":"Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses","volume":"94","author":"Hillaire","year":"2013","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib51","doi-asserted-by":"crossref","first-page":"12057","DOI":"10.1128\/JVI.05204-11","article-title":"Characterization of the human CD8(+) T cell response following infection with 2009 pandemic influenza H1N1 virus","volume":"85","author":"Hillaire","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib52","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.4049\/jimmunol.162.12.7578","article-title":"Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species","volume":"162","author":"Jameson","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2015.12.005_bib53","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1128\/JVI.02694-07","article-title":"Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus","volume":"82","author":"Kreijtz","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib54","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.00519-10","article-title":"Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus","volume":"84","author":"Tu","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.005_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib56","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib57","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","article-title":"Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the Flu Watch Cohort Study","volume":"191","author":"Hayward","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib58","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1038\/ncomms7833","article-title":"Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2015.12.005_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2015.12.005_bib60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/vaccines3020239","article-title":"Developing universal influenza vaccines: hitting the nail, not just on the head","volume":"3","author":"Wiersma","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cmi.2015.12.005_bib61","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1586\/14760584.2015.1060860","article-title":"Universal influenza vaccines, science fiction or soon reality?","volume":"14","author":"de Vries","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2015.12.005_bib62","doi-asserted-by":"crossref","first-page":"e01044","DOI":"10.1128\/mBio.01044-15","article-title":"An intranasal virus-like particle vaccine broadly protects mice from multiple subtypes of influenza A virus","volume":"6","author":"Schwartzman","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.cmi.2015.12.005_bib63","doi-asserted-by":"crossref","first-page":"e88340","DOI":"10.1371\/journal.pone.0088340","article-title":"MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses","volume":"9","author":"Hessel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.005_bib64","doi-asserted-by":"crossref","first-page":"e48322","DOI":"10.1371\/journal.pone.0048322","article-title":"A\u00a0T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years","volume":"7","author":"Antrobus","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.005_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.005_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/cis327","article-title":"Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans","volume":"55","author":"Lillie","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.005_bib67","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3201\/eid2106.150021","article-title":"Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine","volume":"21","author":"de Vries","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.005_bib68","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S1473-3099(14)70963-6","article-title":"Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1\/2a clinical trial","volume":"14","author":"Kreijtz","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.005_bib69","doi-asserted-by":"crossref","first-page":"e7790","DOI":"10.1371\/journal.pone.0007790","article-title":"MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A\/H5N1 viruses at low doses and after single immunization","volume":"4","author":"Kreijtz","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.005_bib70","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/595984","article-title":"Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques","volume":"199","author":"Kreijtz","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.005_bib71","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/517614","article-title":"Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1","volume":"195","author":"Kreijtz","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.005_bib72","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.vaccine.2013.06.047","article-title":"Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24\u201326 January 2013","volume":"31","author":"Girard","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.005_bib73","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1016\/j.vaccine.2012.08.073","article-title":"Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16\u201317 November 2011","volume":"30","author":"Hughes","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.005_bib74","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1016\/j.vaccine.2010.03.074","article-title":"Report of the fourth meeting on \u2018Influenza vaccines that induce broad spectrum and long-lasting immune responses\u2019, World Health Organization and Wellcome Trust, London, United Kingdom, 9\u201310 November 2009","volume":"28","author":"Stephenson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.005_bib75","doi-asserted-by":"crossref","first-page":"e13162","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses","volume":"5","author":"Price","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.005_bib76","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"issue":"6254","key":"10.1016\/j.cmi.2015.12.005_bib77","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A\u00a0stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15010319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15010319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T18:23:50Z","timestamp":1692469430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15010319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":77,"alternative-id":["S1198743X15010319"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.12.005","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}